Kelly A. Chiles

Washington University Medical Center

Papers

1

Total Citations

32

H-Index

1

About

Dr. Kelly A. Chiles is a urologic surgeon and researcher whose work centers on sexual health and functional outcomes following prostate cancer treatment. Her most impactful contribution is a landmark 2017 double-blind, randomized trial investigating hyperbaric oxygenation therapy (HBOT) as a novel approach to preserving erectile function after robot-assisted radical prostatectomy. This study, which has garnered 32 citations, rigorously evaluated HBOT’s efficacy and safety within a penile rehabilitation protocol, addressing a critical gap in post-prostatectomy care. By demonstrating that hyperbaric oxygen may help maintain erectile tissue health, Chiles’ work offers hope for improving quality of life in prostate cancer survivors. Her research bridges surgical oncology and sexual medicine, emphasizing evidence-based strategies to mitigate treatment-related side effects. Beyond this pivotal trial, Chiles contributes to the broader urology literature on erectile dysfunction and penile rehabilitation. Her commitment to rigorous, patient-centered research underscores her role in advancing functional recovery after cancer therapy, making her a key voice in the ongoing effort to balance oncologic control with preservation of sexual function.

Research Focus

Key Achievements

1
H-Index
1
Papers
32
Total Citations
32
Avg Citations/Paper
🏆 Most Cited Paper
A Double-Blind, Randomized Trial on the Efficacy and Safety of Hyperbaric Oxygenation Therapy in the Preservation of Erectile Function after Radical Prostatectomy
32 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Washington University Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago